-
Shenzhen Cell Valley and Guangzhou Tesai Immune signed a strategic cooperation agreementOn November 19, 2023, in the immunotherapy branch of the Fourth Precision Medicine Conference in 2023 held in Guangzhou Yuexiu International Conference Cent...02-11 -
Another great achievement! Shenzhen Cell Valley won the third prize of the "Future of Science and Technology Industry Bay" China Innovation Fair Innovation and Entrepreneurship CompetitionRecently, the office of China Innovation and Entrepreneurship Fair (hereinafter referred to as "China Innovation and Entrepreneurship Fair") release...02-11 -
Building an industrial platform and empowering industry development - Fu Chengbin, President of Guangzhou Institute of Chronic Disease Digital Therapy, and Zhang Rui, Director of Liaoning Cancer HospiOn November 9, Dr. Fu Chengbin, President of Guangzhou Institute of Digital Therapy for Chronic Diseases, Teacher Xu Teng and chief physician Zhang Rui of L...02-11 -
Shenzhen Cell Valley was elected as the vice chairman unit of Shenzhen Biomedicine Production and Education AllianceOn November 1st, Shenzhen Vocational and Technical University (hereinafter referred to as "Shenzhen Vocational University"), as the leading unit, jo...02-11 -
Usher in the growth turning point, seize the opportunity of The Times - Chairman Shi Yuanyuan made a keynote report at the group's general meeting of staffIn order to thoroughly implement the future work deployment of Shenzhen Cell Valley and its subsidiaries, clarify work objectives, gather development consen...02-11 -
Jointly promote TCR-T cell therapy based on retrovirus vector - Professor Li Liangping, Chairman of Tesai Immunity, and his team visited Shenzhen Cell Valley for exchangeOn October 31, Professor Li Liangping, chairman and founder of Tesai Immunization (Guangzhou) Technology Co., Ltd. and his team visited Shenzhen Cell Valley...02-11
